Clinical Trials Browser

Phase 2 × exemestane × Genitourinary × Clear all

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00031889 2012-05-15

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms